NeurAxis to Host Third Quarter 2026 Results and Business Update Call on Monday, November 9, 2026
Globe Newswire•27/10/2026•07:00 ET
0
Key Highlights
- ➤Q3 2026 results scheduled for release before market open November 9
- ➤Conference call set for 9:00 a.m. ET on November 9
- ➤NeurAxis advances IB-Stim neuromodulation therapy for gastrointestinal conditions
- ➤IB-Stim FDA-cleared for IBS, functional dyspepsia, and related nausea in patients 8+
CARMEL, Ind., Oct. 27, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, will report summarized financial results for its third quarter period ended September 30, 2026, on Monday, November 9, 2026, before market open. The Company has scheduled a conference call for the same day, Monday, November 9, 2026, at 9:00 am ET to review the results.
Toll Free: 1-833-862-0272 (U.S. and Canada toll-free) International: 1-412-634-5915 Webcast: https://app.webinar.net/B2bPr8Dro8e
Get started
Create a free account to read the full story.